Variant report
Variant | nsv610170 |
---|---|
Chromosome Location | chr8:8288638-8290350 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183497489 | chr8:8288707-8288708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs77321440 | chr8:8288755-8288756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530212926 | chr8:8288803-8288804 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546827093 | chr8:8288819-8288820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566619503 | chr8:8288832-8288833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143864111 | chr8:8288847-8288848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552644421 | chr8:8288848-8288849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569117829 | chr8:8288849-8288850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575082732 | chr8:8288855-8288856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575850276 | chr8:8288868-8288869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376020227 | chr8:8288906-8288907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557265213 | chr8:8288907-8288908 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188594650 | chr8:8288911-8288912 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372156778 | chr8:8288985-8288986 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544716469 | chr8:8288998-8288999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140654615 | chr8:8288999-8289000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs193126899 | chr8:8289048-8289049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183221677 | chr8:8289050-8289051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10090619 | chr8:8289066-8289067 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs575105632 | chr8:8289067-8289068 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543836195 | chr8:8289089-8289090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111873938 | chr8:8289134-8289135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530369195 | chr8:8289149-8289150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186801851 | chr8:8289190-8289191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs377628307 | chr8:8289197-8289198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74436769 | chr8:8289198-8289199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370915947 | chr8:8289199-8289200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs35747440 | chr8:8289205-8289206 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35678462 | chr8:8289206-8289207 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs60227161 | chr8:8289227-8289228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs142248253 | chr8:8289228-8289229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs58061999 | chr8:8289229-8289230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs71217298 | chr8:8289233-8289234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201595558 | chr8:8289234-8289235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201628929 | chr8:8289235-8289236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs200126768 | chr8:8289236-8289237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2976839 | chr8:8289237-8289238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200300542 | chr8:8289239-8289240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs376989888 | chr8:8289243-8289244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201304407 | chr8:8289244-8289245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs59078718 | chr8:8289245-8289246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs71217299 | chr8:8289246-8289247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552355314 | chr8:8289247-8289248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs569355235 | chr8:8289249-8289250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531585503 | chr8:8289251-8289252 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140491929 | chr8:8289252-8289253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs62498672 | chr8:8289253-8289254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs60530595 | chr8:8289263-8289264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs191320436 | chr8:8289265-8289266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567556017 | chr8:8289269-8289270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:8273200-8289400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr8:8286200-8292600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr8:8287400-8288800 | Weak transcription | HSMMtube | muscle |
4 | chr8:8287400-8289600 | Weak transcription | Placenta Amnion | Placenta Amnion |
5 | chr8:8287600-8289600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr8:8288000-8289400 | Weak transcription | Placenta | Placenta |
7 | chr8:8288400-8289600 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr8:8288800-8290800 | Enhancers | HSMMtube | muscle |
9 | chr8:8289400-8290400 | Enhancers | Placenta | Placenta |
10 | chr8:8289400-8290600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr8:8289400-8290800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
12 | chr8:8289600-8289800 | Enhancers | Fetal Muscle Leg | muscle |
13 | chr8:8289600-8290000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr8:8289600-8290000 | Enhancers | Placenta Amnion | Placenta Amnion |
15 | chr8:8289600-8290600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |